Jessi Stout, owner of the Table Rock Pharmacy fills a prescription on Friday, Jan. 6, 2023, in Morganton, N.C. Drugstore chains are still trying to find enough employees to put a stop to temporary pharmacy closures. Photo by Chris Carlson/AP.
Jessi Stout, owner of the Table Rock Pharmacy fills a prescription on Friday, Jan. 6, 2023, in Morganton, N.C. Drugstore chains are still trying to find enough employees to put a stop to temporary pharmacy closures. Photo by Chris Carlson/AP.

Maryland’s Prescription Drug Affordability Board is set to begin limiting prices in the fall, but don’t expect it to make too many waves in the beginning.

During a July 24 meeting of the organization, board members agreed that a cautious approach to setting upper price limits on drugs as the board gets its feet under it is the best idea.

“There are scenarios where the board should feel comfortable saying, ‘Yes, this drug is not affordable, but maybe an upper payment limit isn’t the right approach,’” said Andrew York, the executive director of the board.

The careful rollout may be because the board is acutely aware that it may be a model for other states in the future.

The state established the board in 2019, and it has since been figuring out how exactly it will push back against pharmaceutical companies on cost. It’s the first state in the nation to do so.

“The idea behind these boards is for states to think about what a fair price would be that can increase access to these drugs for patients within the state,” said Rachel Sachs, a professor of health law at Washington University in St. Louis.

The teeth behind Maryland’s affordability board is the ability to set upper payment limits, a power given to it by the state legislature, and what board members want to be careful in exercising at first.

Read more at WYPR.